Refine
Has Fulltext
- yes (12) (remove)
Is part of the Bibliography
- yes (12)
Year of publication
- 2022 (12) (remove)
Document Type
- Journal article (10)
- Doctoral Thesis (2)
Keywords
- SARS-CoV-2 (12) (remove)
Institute
- Institut für Virologie und Immunbiologie (3)
- Theodor-Boveri-Institut für Biowissenschaften (3)
- Klinik und Poliklinik für Anästhesiologie (ab 2004) (2)
- Center for Computational and Theoretical Biology (1)
- Institut für Anorganische Chemie (1)
- Institut für Hygiene und Mikrobiologie (1)
- Institut für Klinische Epidemiologie und Biometrie (1)
- Institut für Molekulare Infektionsbiologie (1)
- Institut für Organische Chemie (1)
- Kinderklinik und Poliklinik (1)
Sonstige beteiligte Institutionen
EU-Project number / Contract (GA) number
- 101007642 (1)
Acetylsalicylic acid and salicylic acid inhibit SARS-CoV-2 replication in precision-cut lung slices
(2022)
Aspirin, with its active compound acetylsalicylic acid (ASA), shows antiviral activity against rhino- and influenza viruses at high concentrations. We sought to investigate whether ASA and its metabolite salicylic acid (SA) inhibit SARS-CoV-2 since it might use similar pathways to influenza viruses. The compound-treated cells were infected with SARS-CoV-2. Viral replication was analysed by RTqPCR. The compounds suppressed SARS-CoV-2 replication in cell culture cells and a patient-near replication system using human precision-cut lung slices by two orders of magnitude. While the compounds did not interfere with viral entry, it led to lower viral RNA expression after 24 h, indicating that post-entry pathways were inhibited by the compounds.